Cagrilintide Phase 2 monotherapy (Lau et al., Lancet 2021) reported about 10.8% weight loss at 26 weeks at 4.5 mg
Therefore, the acute slope included data only for the European patients for whom these timepoints were evaluated
Pharmacological approaches include DPP-4 inhibitors, which prevent GLP-1 degradation, and GLP-1 receptor agonists, both approved by NICE for type 2 diabetes management in appropriate patients according to treatment guidelines
Hoover published in 1941, were the action of pepsin on native and urea-denatured proteins were compared (Lineweaver and Hoover, 1941)
You never really know if it's cocaine and you can just OD on some crazy ass pink cocaine that's not even cocaine anymore
What do we mean by GLP-1 medications